01080nam a2200217 c 4500001001300000005001500013007000300028008004100031040001100072041001300083052003000096245023200126300002400358545008700382545006600469653006500535700005300600700004500653773014700698900001700845KSI00073158420090814112823ta090204s2003    ulk           000   kor    a0110010 akorbeng01a514.4405b대447ㄷc3(2)00a갑상선암 세포주에서 troglitazone에 의한 TRAIL-유도 세포소멸 감수성의 증가 =xTroglitazone increases the susceptibility to TRAIL-induced apoptosis in thyroid cancer cell lines /d박진우,eOrlo H. Clark  ap. 113-120 ;c28 cm  a박진우, 충북대학교 의과대학 외과학교실bjwpark@med.chungbuk.ac.kr  aOrlo H. Clark, Department of Surgery University of California  aTRAILaApoptosisaThyroid cancera세포소멸a갑상선암1 a박진우,g朴珍佑,d1963-0KAC2018065084aut1 aClark, Orlo H.,d1941-20220KAC2023631760 t대한내분비외과학회지.d대한내분비외과학회.g3권 2호(2003년 10월), p. 113-120q3:2<113w(011001)KSE200102799,x1598-170310aPark, Jinwoo